The purpose of this study is to provide data to assess Dysport™ injections as a treatment
therapy for brow ptosis. This study will assess the outcome of brow lifting with use of
Dysport.
Phase:
Phase 4
Details
Lead Sponsor:
Kenneth Beer
Collaborator:
Medicis Pharmaceutical Corporation
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA